Eyenuk, Inc., is a global artificial intelligence (AI) medical technology company and the leader in real-world AI Eye Screening™ for autonomous disease detection and AI Predictive Biomarkers™ for risk assessment and disease surveillance.
Harnessing the power of AI to analyze retinal images was the inspiration of Eyenuk Founder & CEO Kaushal Solanki. During his own health scare, Solanki faced a four-month long wait to see a specialist about his retinal scans. His own father’s struggle with diabetes led Solanki to better understand the risks of diabetic retinopathy, as well as the shortage of qualified professionals to address the issue.
Member of the Board of Directors, Eyenuk, Inc.
Assistant Clinical Professor,
Director of Clinical Infomatics Research, Optometry,
University of California, Berkeley, CA.
Los Angeles, CA
Ophthalmology and Visual Sciences,
Washington University School of Medicine,
St. Louis, MO
Division of Medicine,
The University of Manchester, U.K
Abbott Diabetes Care,
San Francisco, CA